|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's range||88.60 - 88.60|
|52-week range||78.78 - 97.00|
|Beta (5Y monthly)||0.53|
|PE ratio (TTM)||20.47|
|Forward dividend & yield||3.22 (3.69%)|
|Ex-dividend date||04 Mar 2021|
|1y target est||N/A|
Unilever decides that it will not raise its offer of $68 billion for Glaxo's (GSK) Consumer Healthcare business.
Still earning peanuts in your savings account? These 3 income stocks might help.
Ionis' (IONS) partner, Roche, is planning a new phase II study to evaluate tominersen for the treatment of Huntington's disease.